Sage Therapeutics Inc (NASDAQ:SAGE) has a beta value of 0.17 and has seen 1.78 million shares traded in the last trading session. The SAGE stock price is -44.84% off its 52-week high price of $13.47 and 50.32% above the 52-week low of $4.62. If we look at the company’s 10-day average daily trading volume, we find that it stood at 4.19 million shares traded. The 3-month trading volume is 1.51 million shares.
The consensus among analysts is that Sage Therapeutics Inc (SAGE) is Hold stock at the moment, with a recommendation rating of 2.88. 1 analysts rate the stock as a Sell, while 0 rate it as Overweight. 4 out of 8 have rated it as a Hold, with 3 advising it as a Buy. 0 have rated the stock as Underweight.
Sage Therapeutics Inc (NASDAQ:SAGE) trade information
Over the past 30 days, the shares of Sage Therapeutics Inc (NASDAQ:SAGE) have changed 36.76%. Short interest in the company has seen 5.2 million shares shorted with days to cover at 6.04.
Wall Street analysts have a consensus price target for the stock at $7, which means that the shares’ value could drop -32.86% from current levels. The projected low price target is $5.0 while the price target rests at a high of $9.0. In that case, then, we find that the current price level is 3.23% off the targeted high while a plunge would see the stock lose 46.24% from current levels.
Sage Therapeutics Inc (SAGE) estimates and forecasts
The company’s shares have gained 76.47% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 13.20% over the past 5 years. Earnings growth for 2025 is a modest 46.38% while over the next 5 years, the company’s earnings are expected to increase by 35.62%.
SAGE Dividends
Sage Therapeutics Inc is expected to release its next earnings report on 2025-Apr-29 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Sage Therapeutics Inc (NASDAQ:SAGE)’s Major holders
Insiders own 10.41% of the company shares, while shares held by institutions stand at 83.72% with a share float percentage of 93.44%. Investors are also buoyed by the number of investors in a company, with Sage Therapeutics Inc having a total of 255.0 institutions that hold shares in the company. The top two institutional holders are VANGUARD GROUP INC with over 6.42 million shares worth more than $69.68 million. As of 2024-06-30, VANGUARD GROUP INC held 10.5988% of shares outstanding.
The other major institutional holder is FMR LLC, with the holding of over 5.82 million shares as of 2024-06-30. The firm’s total holdings are worth over $63.24 million and represent 9.6193% of shares outstanding.
